Peter Iversen - Concepedia

Author

Peter Iversen

Also Known As

Børge G. Nordestgaard, Iversen P, Iversen, Peter, John, E.M., K. Griffiths, P IVERSEN, P Iversen, P. Iversen, P.O. Iversen, PETER IVERSEN

373

Publications

13.9K

Citations

H-Index

130

Concepts

All Affiliations

Rigshospitalet University of Copenhagen Aarhus University Hospital Copenhagen University Hospital Herlev Hospital

About

Peter Iversen is an author at Rigshospitalet specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	61	3.6K
2	Health Sciences	10	10	824
3	Engineering	2	2	71
4	Public Health	2	2	106
5	Social Sciences	2	2	46

Peter Iversen

130

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, New England Journal of Medicine	2014	3K
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, European Urology UrologyOncologyMedicinePharmacotherapyPrevail Study	2016	408
BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP Peter Iversen, C. Tyrrell, Amir V. Kaisary, The Journal of Urology	2000	345
A Randomised Comparison of &lsquo;Casodex&rsquo;<sup>TM</sup> (Bicalutamide) 150&nbsp;mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer CJ Tyrrell, Amir Kaisary, Peter Iversen, European Urology UrologyMedicineClinical TrialsMonotherapy Versus CastrationRandomised Comparison	1998	307
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer David G. McLeod, Peter Iversen, William A. See, British Journal of Urology	2005	279
Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program William A. See, Manfred P. Wirth, David G. McLeod, The Journal of Urology	2002	229
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts Tyler M. Seibert, Chun Chieh Fan, Yunpeng Wang, BMJ	2018	216
BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS Manfred P. Wirth, William A. See, David G. McLeod, The Journal of Urology	2004	209
Brain Energy Metabolism and Blood Flow Differences in Healthy Aging Joel Aanerud, Per Borghammer, M. Mallar Chakravarty, Journal of Cerebral Blood Flow & Metabolism AgingBrain FunctionCerebral Metabolic RateCerebral Vascular RegulationAlzheimer's Disease	2012	173
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years Peter Iversen, C. Tyrrell, Amir V. Kaisary, Urology Surgical OncologyUrologyGenitourinary CancerMedicineMedian Follow-up	1998	164

Page 1